Pfizer reportedly has launched a review for the creative account for Advil, which it added via its 2009 takeover of Wyeth Consumer Healthcare. Incumbent WPP Group's Grey is said to be participating in the review for the business, for which spending is $80 million. Neither Grey nor Pfizer commented for this article.

Related Summaries